Core Insights - The company held a performance briefing for the first half of 2025, emphasizing the stability of its main business segments: traditional Chinese medicine, Western medicine, and non-pharmaceutical products [1] - Following the release of the "Special Action Plan to Promote Healthy Consumption" by the state in April 2025, policies encouraging diversified development in pharmacies are expected to drive growth in related sectors [1] Company Strategy - The company has established a non-pharmaceutical innovation division focusing on product innovation in functional and non-functional foods and supplies, including medical beauty skincare, personal care, and household cleaning products [1] - As community health access points, pharmacies benefit from high consumer trust and low marginal operating costs, allowing the company to validate its market through mainstream branded products [1] - Future strategies will involve deepening product selection based on health dimensions, quality screening, and cost-performance strategies, along with gradually expanding self-owned brands [1] Industry Trends - According to third-party statistics, the number of pharmacies in China reached a critical point in 2024, leading to a decline in single-store sales and profitability [1] - The period from 2025 to 2026 is expected to see a normalization of both openings and closures of stores, with an acceleration in industry consolidation [1] - For leading chains, adapting to changes in the era and policies, along with digital transformation, supply chain optimization, and innovative service models for health management across online and offline channels, will be key competitive advantages [1]